Exclusive

Publication

Byline

Location

US Patent Issued to AB2 BIO on July 14 for "IL-18 binding protein (IL-18BP) and antibodies for treating inflammatory diseases" (Swiss Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,888, issued on July 14, was assigned to AB2 BIO SA (Lausanne, Switzerland). "IL-18 binding protein (IL-18BP) and antibodies for treating in... Read More


US Patent Issued to Eli Lilly and Co. on July 14 for "Oxyntomodulin binding molecules, and uses thereof" (Indiana Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,889, issued on July 14, was assigned to Eli Lilly and Co. (Indianapolis). "Oxyntomodulin binding molecules, and uses thereof" was invented ... Read More


US Patent Issued to CSPC Megalith Biopharmaceutical on July 14 for "Anti-claudin 18 antibodies and methods of use thereof" (Pennsylvania, New Jersey, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,890, issued on July 14, was assigned to CSPC Megalith Biopharmaceutical Co. Ltd. (Hebei, China). "Anti-claudin 18 antibodies and methods of... Read More


US Patent Issued to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, UNIVERSITY OF RIJEKA FACULTY OF MEDICINE on July 14 for "Antibodies to NKP46 and constructs thereof for treatment of cancers and infections" (Israeli, Croatian Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,891, issued on July 14, was assigned to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (Jerusalem) and UNIVER... Read More


US Patent Issued to FIVE PRIME THERAPEUTICS on July 14 for "B7-H4 antibodies and methods of use thereof" (California, New Hampshire Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,892, issued on July 14, was assigned to FIVE PRIME THERAPEUTICS INC. (Thousand Oaks, Calif.). "B7-H4 antibodies and methods of use thereof"... Read More


US Patent Issued to EXELIXIS on July 14 for "PD-L1 binding agents and uses thereof" (Wisconsin, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,893, issued on July 14, was assigned to EXELIXIS INC. (Alameda, Calif.). "PD-L1 binding agents and uses thereof" was invented by Bryan Glas... Read More


US Patent Issued to Cullinan Mica on July 14 for "Anti-MICA/B antibodies that block MICA/B shedding and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,894, issued on July 14, was assigned to Cullinan Mica Corp (Cambridge, Mass.). "Anti-MICA/B antibodies that block MICA/B shedding and metho... Read More


US Patent Issued to Bio-Thera Solutions on July 14 for "Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,895, issued on July 14, was assigned to Bio-Thera Solutions Ltd. (Guangzhou, China). "Recombinant antibody having unique glycan profile pro... Read More


US Patent Issued to PIERRE FABRE MEDICAMENT on July 14 for "Anti-cMET antibody" (French Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,896, issued on July 14, was assigned to PIERRE FABRE MEDICAMENT (Boulogne-Billancourt, France). "Anti-cMET antibody" was invented by Lilian... Read More


US Patent Issued to GALAXY BIOTECH on July 14 for "Monoclonal antibodies to fibroblast growth factor receptor 2" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,897, issued on July 14, was assigned to GALAXY BIOTECH LLC (Cupertino, Calif.). "Monoclonal antibodies to fibroblast growth factor receptor... Read More